介素-1受体关联激酶-3的甲基化和多发性硬化症复发/活动的风险
Mona M Watany1, Marwa M Elhosary2, Hemat E El-Horany3
1Clinical pathology department, Faculty of Medicine, Tanta University, Tanta 31527, Egypt.
Clinical immunology (Orlando, Fla.)
|July 25, 2024
概括
甲基化沉默介质素-1受体关联激酶-3 (IRAK-3) 与多发性硬化症 (MS) 的活性有关. 较高的IRAK-3甲基化预测MS复发风险,这表明它是一个潜在的生物标志物.
科学领域:
- 神经免疫学 神经免疫学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 生物标志物发现发现
背景情况:
- 多发性硬化症 (MS) 是中枢神经系统的慢性炎症性脱髓化疾病.
- 表观遗传修饰,如DNA甲基化,与自身免疫性疾病的发病有关.
- 介素-1受体关联激酶-3 (IRAK-3/IRAK-M) 在免疫调节中发挥作用,其通过甲基化沉默在这里被研究.
研究的目的:
- 调查IRAK-3甲基化与多发性硬化症 (MS) 疾病活动之间的关联.
- 评估IRAK-3甲基化作为预测MS复发的潜在生物标志物.
- 探索IRAK-3甲基化,IRAK-3mRNA表达,MyD88和MS患者NF-κB活性之间的关系.
主要方法:
- 追溯横截面研究涉及90名参与者:45名患有活跃多发性硬化症,45名患有缓解期多发性硬化症和45名健康对照.
- 量化IRAK-3甲基化指数 (MI%),IRAK-3mRNA水平,循环骨髓分化因子88 (MyD88) 和核因子-卡帕B (NF-κB) 活性.
- 统计分析包括相关联和后勤回归建模,以评估预测值.
主要成果:
- 与缓解期患者相比,在活跃的MS患者中,IRAK-3MI%显著升高.
- 较高的IRAK-3MI%与较低的IRAK-3mRNA表达相关,MyD88增加,NF-κB活性增加.
- 结合IRAK-3甲基化的后勤回归模型显示了活性脱髓化强大的预测能力 (C指数=0.924).
结论:
- 伊拉克-3甲基化与活跃的多发性硬化症有显著的关联.
- 伊拉克-3甲基化作为一个有希望的候选生物标志物,用于识别患有复发风险的多发性硬化症患者.
- 通过调节MyD88/NF-κB通路,IRAK-3的表观遗传沉默可能有助于MS的发病.
相关概念视频
T Cell Types and Functions
986
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
986
Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K


